EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nitric oxide synergizes minoxidil delivered by transdermal hyaluronic acid liposomes for multimodal androgenetic-alopecia therapy

Hui Xing, Huanqi Peng, Yuhui Yang, Kai Lv, Shihao Zhou, Xiangjun Pan, Jianjin Wang, Yunfeng Hu, Guowei Li, Dong Ma

Bioactive Materials · 2024-02 · 32 · 190-205

DOI: 10.1016/j.bioactmat.2023.09.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioactive Materials, 2024-02. Verfasst von Hui Xing und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, 510630, China. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Jinan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Androgenetic alopecia (AGA) is a common clinical condition, affecting over 200 million people globally each year. For decades, Minoxidil (Mi) tincture has been the primary treatment for this disease, but its low utilization rate and significant side effects necessitate new therapeutic strategies. Nitric oxide (NO) is a signaling molecule in various physiological processes, including vasodilation, immune responses, and cell proliferation. Herein, we constructed a hyaluronic acid liposome (HL) complex as a novel transdermal delivery system (HL@Mi/NONOate) for NO and Mi, which displayed promising transdermal and hair-regrowth effects. In-depth mechanistic studies revealed three potential pathways of the synergistic AGA therapy. First, NO promoted capillary dilation and accelerated blood flow, thus achieving efficient penetration of Mi. Due to the structural advantage of liposomes, the residence time of the Mi in the skin was prolonged. Moreover, HL@Mi/NONOate promoted cell proliferation and angiogenesis, and upregulated the expression of regulatory factors involved in follicle stem cell differentiation. In the AGA model, HL@Mi/NONOate down-regulated the expression of inflammatory factors, inhibiting the inflammation of follicle and improving the microenvironment of hair regrowth. Concurrently, HL@Mi/NONOate upregulated the expression of Ki67 and PCNA proteins in follicle tissues, inducing follicle regeneration and development, ultimately achieving the synergistic multimodal AGA therapy.

Schlagwörter

Stichwörter der Autor:innen

Androgenetic alopeciaEnhanced penetrationLiposomeNitric oxideSynergistic therapy

Autor:innen und Institutionen

  • The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, 510630, China.
  • Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China.
  • Honest Medical China Co., Ltd, Zhuhai, 519000, China.
  • Department of Nuclear Medicine and PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, 510630, China.
  • MOE Key Laboratory of Tumor Molecular Biology, Jinan University, Guangzhou, 510632, China.

Förderung

  • National Natural Science Foundation of China
  • Jinan University

Zitieren

APA

Xing, H., Peng, H., Yang, Y., Lv, K., Zhou, S., Pan, X., Wang, J., Hu, Y., Li, G., & Ma, D. (2024). Nitric oxide synergizes minoxidil delivered by transdermal hyaluronic acid liposomes for multimodal androgenetic-alopecia therapy. Bioactive Materials, 32, 190-205. https://doi.org/10.1016/j.bioactmat.2023.09.021

Vancouver

Xing H, Peng H, Yang Y, Lv K, Zhou S, Pan X, et al. Nitric oxide synergizes minoxidil delivered by transdermal hyaluronic acid liposomes for multimodal androgenetic-alopecia therapy. Bioactive Materials. 2024;32:190-205. doi:10.1016/j.bioactmat.2023.09.021

BibTeX
@article{Xing2024,
  author = {Xing, Hui and Peng, Huanqi and Yang, Yuhui and Lv, Kai and Zhou, Shihao and Pan, Xiangjun and Wang, Jianjin and Hu, Yunfeng and Li, Guowei and Ma, Dong},
  title = {Nitric oxide synergizes minoxidil delivered by transdermal hyaluronic acid liposomes for multimodal androgenetic-alopecia therapy},
  journal = {Bioactive Materials},
  year = {2024},
  volume = {32},
  pages = {190--205},
  doi = {10.1016/j.bioactmat.2023.09.021}
}
Kostenlos starten →